<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03645577</url>
  </required_header>
  <id_info>
    <org_study_id>18-151A</org_study_id>
    <nct_id>NCT03645577</nct_id>
  </id_info>
  <brief_title>Phrenic Nerve Injury During Pulmonary Vein Isolation With the Second-generation Cryoballoon.</brief_title>
  <acronym>YETI-Registry</acronym>
  <official_title>Phrenic Nerve Injury During Pulmonary Vein Isolation With the Second-generation Cryoballoon: Clinical, Procedural, and Anatomical Characteristics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Principal Investigator: Roland Richard Tilz, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the most frequent complication associated with cryoballoon PVI. The main
      hypothesis is to explore the incidence of phrenic nerve palsy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 24, 2018</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of phrenic nerve palsy</measure>
    <time_frame>06/2012 until 04/2018</time_frame>
    <description>The overall incidence of phrenic nerve palsy during second and third Generation Cryoballoon based PVI will be evaluated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictors of phrenic nerve palsy</measure>
    <time_frame>06/2012 until 04/2018</time_frame>
    <description>Predictors for transient and permanent phrenic nerve palsy will be evaluated. For this purpose baseline characteristics (e.g. age, sex, BMI, CHADS-VASc-Score) as well as periprocedural data (e.g. minimal cryoballoon temp., cryoballoon temp. after 30 seconds, time to isolation, PV diameter, use of doublestopp technique and draw back manouever) will be assesseda and predictors will be calculated using adequat statistical techniques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical course of phrenic nerve palsy</measure>
    <time_frame>06/2012 until 04/2018</time_frame>
    <description>The clincial course of phrenic nerve palsy after second and third Generation Cryoballoon based PVI will be evaluated by follow-up appointments according to each centers standard of care. For this purpose follow-up data will be evaluated and the clinical course will be assessed.</description>
  </secondary_outcome>
  <enrollment type="Actual">731</enrollment>
  <condition>Phrenic Nerve Palsy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who underwent a PVI by the second generation Cryoballoon.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years or older

          -  Cryoballoon PVI

          -  Periprocedural phrenic lesion

        Exclusion Criteria:

        - Non
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Heart Center Luebeck, Electrophysiology</name>
      <address>
        <city>Luebeck</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>July 26, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>November 30, 2019</last_update_submitted>
  <last_update_submitted_qc>November 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Luebeck</investigator_affiliation>
    <investigator_full_name>Christian-H. Heeger, MD</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Pulmonary vein isolation</keyword>
  <keyword>Phrenic nerve palsy</keyword>
  <keyword>Paroxysmal atrial fibrillation</keyword>
  <keyword>Persistent atrial fibrillation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

